JP Morgan Chase
EXAS

JP Morgan Chase’s Exact Sciences EXAS Stock Holding History

JP Morgan Chase’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-674,621
Closed -$68.5M – 7637
2025
Q4 		$68.5M Sell
674,621
-95,276
-12% -$7.65M ﹤0.01% 1163
2025
Q3 		$42.1M Buy
769,897
+176,639
+30% +$8.83M ﹤0.01% 1518
2025
Q2 		$31.5M Buy
593,258
+89,289
+18% +$4.54M ﹤0.01% 1626
2025
Q1 		$21.8M Sell
503,969
-2,989,522
-86% -$151M ﹤0.01% 1866
2024
Q4 		$196M Sell
3,493,491
-1,762,792
-34% -$110M 0.01% 672
2024
Q3 		$358M Buy
5,256,283
+914,682
+21% +$51.6M 0.03% 483
2024
Q2 		$183M Sell
4,341,601
-8,042,915
-65% -$443M 0.02% 686
2024
Q1 		$855M Sell
12,384,516
-4,306,292
-26% -$272M 0.07% 258
2023
Q4 		$1.23B Sell
16,690,808
-1,601,811
-9% -$105M 0.12% 175
2023
Q3 		$1.25B Buy
18,292,619
+3,293,699
+22% +$279M 0.14% 153
2023
Q2 		$1.41B Buy
14,998,920
+1,048,128
+8% +$81.8M 0.15% 144
2023
Q1 		$946M Buy
13,950,792
+6,201,076
+80% +$399M 0.12% 189
2022
Q4 		$384M Buy
7,749,716
+3,115,288
+67% +$127M 0.05% 352
2022
Q3 		$151M Sell
4,634,428
-488,962
-10% -$20.2M 0.02% 575
2022
Q2 		$202M Sell
5,123,390
-133,113
-3% -$7.12M 0.03% 506
2022
Q1 		$368M Buy
5,256,503
+537,107
+11% +$39.3M 0.04% 380
2021
Q4 		$367M Buy
4,719,396
+353,329
+8% +$31.2M 0.04% 412
2021
Q3 		$417M Sell
4,366,067
-964,931
-18% -$102M 0.05% 362
2021
Q2 		$663M Buy
5,330,998
+170,164
+3% +$20.3M 0.08% 264
2021
Q1 		$680M Sell
5,160,834
-1,385,942
-21% -$190M 0.09% 240
2020
Q4 		$867M Buy
6,546,776
+1,481,633
+29% +$179M 0.13% 181
2020
Q3 		$517M Buy
5,065,143
+84,827
+2% +$7.33M 0.09% 227
2020
Q2 		$433M Sell
4,980,316
-1,126,000
-18% -$90M 0.08% 241
2020
Q1 		$354M Buy
6,106,316
+786,669
+15% +$63.9M 0.08% 251
2019
Q4 		$492M Buy
5,319,647
+165,126
+3% +$14.5M 0.09% 234
2019
Q3 		$466M Sell
5,154,521
-142,845
-3% -$16.3M 0.09% 241
2019
Q2 		$610M Buy
5,297,366
+1,999,725
+61% +$201M 0.12% 180
2019
Q1 		$286M Sell
3,297,641
-52,072
-2% -$4.43M 0.06% 334
2018
Q4 		$211M Sell
3,349,713
-46,224
-1% -$3.17M 0.05% 386
2018
Q3 		$268M Buy
3,395,937
+537,266
+19% +$35M 0.05% 372
2018
Q2 		$171M Buy
2,858,671
+339,075
+13% +$18.2M 0.04% 482
2018
Q1 		$102M Sell
2,519,596
-195,582
-7% -$9.54M 0.02% 624
2017
Q4 		$143M Sell
2,715,178
-155,167
-5% -$8.29M 0.03% 509
2017
Q3 		$133M Sell
2,870,345
-867,368
-23% -$34.9M 0.03% 526
2017
Q2 		$132M Sell
3,737,713
-1,247,944
-25% -$38.5M 0.03% 522
2017
Q1 		$118M Buy
4,985,657
+2,468,376
+98% +$48.9M 0.03% 569
2016
Q4 		$33.6M Sell
2,517,281
-31,842
-1% -$514K 0.01% 1131
2016
Q3 		$47.3M Sell
2,549,123
-236,868
-9% -$4.17M 0.01% 866
2016
Q2 		$34.1M Sell
2,785,991
-22,546
-0.8% -$170K 0.01% 1032
2016
Q1 		$18.9M Sell
2,808,537
-155,199
-5% -$993K ﹤0.01% 1371
2015
Q4 		$27.4M Buy
2,963,736
+2,147,669
+263% +$20M 0.01% 1129
2015
Q3 		$14.7M Sell
816,067
-792,410
-49% -$18.2M ﹤0.01% 1475
2015
Q2 		$47.8M Sell
1,608,477
-377,239
-19% -$9.48M 0.01% 899
2015
Q1 		$43.7M Buy
1,985,716
+479,408
+32% +$12.2M 0.01% 958
2014
Q4 		$41.3M Buy
1,506,308
+66,665
+5% +$1.62M 0.01% 1028
2014
Q3 		$27.9M Buy
1,439,643
+249,172
+21% +$4.57M 0.01% 1239
2014
Q2 		$20.3M Buy
1,190,471
+93,767
+9% +$1.29M 0.01% 1338
2014
Q1 		$15.5M Buy
1,096,704
+45,072
+4% +$609K ﹤0.01% 1479
2013
Q4 		$12.4M Sell
1,051,632
-2,206,189
-68% -$25.3M ﹤0.01% 1644
2013
Q3 		$38.4M Sell
3,257,821
-949,877
-23% -$12.2M 0.01% 937
2013
Q2 		$58.5M Buy
+4,207,698
New +$45.7M 0.02% 694

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

JP Morgan Chase's EXAS Position: Q1 2026 in Review

JP Morgan Chase sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 674,621 shares — an estimated $68.5M sold.

JP Morgan Chase first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $1.41B in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • JP Morgan Chase reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 674,621 Exact Sciences shares in Q1 2026, an estimated $68.5M.
  • JP Morgan Chase first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • JP Morgan Chase's Exact Sciences position peaked at $1.41B in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.